← Leaderboards
Akhilesh Pandey
Brigham And Women'S Hospital
$12,726,065
Attributed
$15,978,851
Total exposure
23
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,978,851 · 23
By mechanism
U01$6,505,573 · 3
R01$2,959,975 · 2
P50$2,054,964 · 2
S10$1,576,479 · 2
U54$1,531,154 · 8
P30$839,902 · 2
Top collaborators
- Rafael Fonseca4 shared
- Ted M. Dawson3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Anny Xiaobo Zhou$14,633,236
- Edwin K Silverman$89,199,838
- Mark A. Rubin$21,732,421
Others in their field
Top investigators on “Proteomics”
- David Heimbrook · Leidos Biomedical Research, Inc.$318,825,229
- Stanley M Lemon · Univ Of North Carolina Chapel Hill$110,612,005
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$70,176,616
- Rolf Apweiler · European Molecular Biology Laboratory$67,677,991
- Daniel Ernest Ford · Johns Hopkins University$67,257,868
Research focus
ProteomicsProteinsSamplingPeptidesMass Spectrum AnalysisProteomeResourcesPathway InteractionsPost-Translational Protein ProcessingTechnologyResearch PersonnelBaseSignal TransductionMediatingPhosphorylationLabelUniversitiesResolutionInstrumentBioinformaticsSiteFundingPlayComplex
Grant awards (47)
Mayo Clinic Center for Clinical Proteomics$1,115,210
U01 · FY2025 · CA · contact PI
Proteomics Shared Resource$193,732
P30 · FY2025 · CA · contact PI
Investigation of Neural Pathogenic Mechanisms Associated with Congenital Disorders of Glycosylation$190,473
P01 · FY2025 · NS · contact PI
Mayo Clinic Center for Clinical Proteomics$914,099
U01 · FY2024 · CA · contact PI
Mayo Clinic Center for Clinical Proteomics$1,101,893
U01 · FY2023 · CA · contact PI
Proteomics Shared Resource$160,901
P30 · FY2023 · CA · contact PI
Mayo Clinic Center for Clinical Proteomics$1,140,564
U01 · FY2022 · CA · contact PI
Proteomics Shared Resource$161,025
P30 · FY2022 · CA · contact PI
Proteomics Shared Resource$160,901
P30 · FY2021 · CA · contact PI
Proteomics Shared Resource$163,343
P30 · FY2020 · CA · contact PI
Personalized Therapy of Hormone Refractory Breast Cancer$352,801
R01 · FY2019 · CA · contact PI
BIOMARKER DISCOVERY AND VALIDATION IN PSP$928,403
U01 · FY2018 · NS
Biomarker Discovery and Validation in Parkinson's Disease$644,960
U01 · FY2018 · NS
Personalized Therapy of Hormone Refractory Breast Cancer$370,575
R01 · FY2018 · CA · contact PI
Establishing clinical utility of CSF biomarkers for PD$200,473
P50 · FY2018 · NS · contact PI
Proteomic Core$193,793
P50 · FY2018 · NS · contact PI
Biomarker Discovery and Validation in Parkinson's Disease$660,444
U01 · FY2017 · NS
Personalized Therapy of Hormone Refractory Breast Cancer$370,575
R01 · FY2017 · CA · contact PI
Establishing clinical utility of CSF biomarkers for PD$200,473
P50 · FY2017 · NS · contact PI
Proteomic Core$193,793
P50 · FY2017 · NS · contact PI
Fourier Transform Orbitrap Fusion Lumos Tribrid Mass Spectrometer with ETD$1,081,149
S10 · FY2016 · OD · contact PI
Personalized Therapy of Hormone Refractory Breast Cancer$370,575
R01 · FY2016 · CA · contact PI
Establishing clinical utility of CSF biomarkers for PD$200,473
P50 · FY2016 · NS · contact PI
Proteomic Core$193,793
P50 · FY2016 · NS · contact PI
Personalized Therapy of Hormone Refractory Breast Cancer$370,575
R01 · FY2015 · CA · contact PI
Establishing clinical utility of CSF biomarkers for PD$200,473
P50 · FY2015 · NS · contact PI
Proteomic Core$193,793
P50 · FY2015 · NS · contact PI
Establishing clinical utility of CSF biomarkers for PD$243,000
P50 · FY2014 · NS · contact PI
Proteomic Core$234,900
P50 · FY2014 · NS · contact PI
Quadrupole time-of-flight mass spectrometer$495,330
S10 · FY2010 · RR · contact PI
TCP3: QUALITATIVE & QUANTITATIVE PROTEOMIC ANALYSIS OF LYSINE MODIFICATIONS$392,654
U54 · FY2008 · RR · contact PI
Molecular Dissection of Growth Factor Receptor Signaling$276,404
R01 · FY2008 · CA · contact PI
CORE 5: TECHNOLOGY DISSEMINATION$26,177
U54 · FY2008 · RR · contact PI
DEVELOPMENT OF SITE FOR DEPOSITION OF PROTEOMIC, OTHER PROTEIN ANALYTICAL DATA$650
P41 · FY2008 · RR · contact PI
TCP3: QUALITATIVE & QUANTITATIVE PROTEOMIC ANALYSIS OF LYSINE MODIFICATIONS$368,310
U54 · FY2007 · RR · contact PI
Molecular Dissection of Growth Factor Receptor Signaling$276,123
R01 · FY2007 · CA · contact PI
CORE 5: TECHNOLOGY DISSEMINATION$24,591
U54 · FY2007 · RR · contact PI
DEVELOPMENT OF SITE FOR DEPOSITION OF PROTEOMIC, OTHER PROTEIN ANALYTICAL DATA$1,077
P41 · FY2007 · RR · contact PI
TCP3: QUALITATIVE & QUANTITATIVE PROTEOMIC ANALYSIS OF LYSINE MODIFICATIONS$349,201
U54 · FY2006 · RR · contact PI
Molecular Dissection of Growth Factor Receptor Signaling$283,503
R01 · FY2006 · CA · contact PI
CORE 5: TECHNOLOGY DISSEMINATION$23,280
U54 · FY2006 · RR · contact PI
TCP3: QUALITATIVE &QUANTITATIVE PROTEOMIC ANALYSIS OF LYSINE MODIFICATIONS$325,257
U54 · FY2005 · RR
Molecular Dissection of Growth Factor Receptor Signaling$288,844
R01 · FY2005 · CA
CORE 5: TECHNOLOGY DISSEMINATION$21,684
U54 · FY2005 · RR
SIGNAL TRANSDUCTION THROUGH TH ERYTHROPOIETIN RECEPTOR$87,233
K01 · FY2001 · CA
SIGNAL TRANSDUCTION THROUGH TH ERYTHROPOIETIN RECEPTOR$72,045
K01 · FY2001 · CA
SIGNAL TRANSDUCTION THROUGH TH ERYTHROPOIETIN RECEPTOR$159,326
K01 · FY2000 · CA